Corcept Therapeutics Incorporated | Business Contracts

Amendment No. 2 to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, made and entered into as of September 16, 2022 (Filed With SEC on November 3, 2022)

Form of 2012 Incentive Award Plan Restricted Stock Award Grant Notice and Agreement (Filed With SEC on August 4, 2022)

Description of Common Stock (Filed With SEC on February 23, 2021)

Sixth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of July Sixth Amendment to Office... (Filed With SEC on November 3, 2020)

Amendment to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, made and entered into as of August 1, 2022 (Filed With SEC on November 3, 2022)

Task Order Number One to Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Filed With SEC on November 3, 2022)

Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Filed With SEC on November 3, 2022)

Form of 2012 Incentive Award Plan Restricted Stock Unit Grant Notice and Agreement (Filed With SEC on August 4, 2022)

Form of 2012 Incentive Award Plan Stock Option Grant Notice and Agreement (Filed With SEC on February 15, 2022)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and William Guyer, dated February 9, 2022 (Filed With SEC on February 15, 2022)

Employment offer letter to William Guyer, dated July 2, 2021 (Filed With SEC on February 15, 2022)

Separation Agreement by and between Corcept Therapeutics Incorporated and Andreas Grauer, M.D., dated August 11, 2021 (Filed With SEC on August 13, 2021)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Atabak Mokari, dated March 1, 2021 (incorporated by reference to Exhibit 10.2 to the... (Filed With SEC on May 6, 2021)

Offer of Employment to Atabak Mokari, dated March 1, 2021 (incorporated by reference to Exhibit 10.1 to the registrant's Form 8-K filed on March 1, 2021) (Filed With SEC on May 6, 2021)

Employment Offer Letter to Atabak Mokari, dated December 21, 2020 (Filed With SEC on March 1, 2021)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Atabak Mokari, dated March 1, 2021 (Filed With SEC on March 1, 2021)

Fifth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of June 17, 2020 (Filed With SEC on August 4, 2020)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Sean Maduck, dated August 3, 2020 (Filed With SEC on August 4, 2020)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Joseph Douglas Lyon, dated August 3, 2020 (Filed With SEC on August 4, 2020)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Hazel Hunt, dated August 3, 2020 (Filed With SEC on August 4, 2020)

Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, effective as of April 1, 2016 (Filed With SEC on February 24, 2020)

Fourth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of October 23, 2019 (Filed With SEC on February 24, 2020)

Third Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of November 8, 2018 (Filed With SEC on February 24, 2020)

Second Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of March 12, 2018 (Filed With SEC on February 24, 2020)

First Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of June 1, 2017 (Filed With SEC on February 24, 2020)

Description of Common Stock (Filed With SEC on February 24, 2020)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Andreas Grauer, M.D., dated March 18, 2019 (Filed With SEC on May 9, 2019)

Employment offer letter to Andreas Grauer, M.D. dated March 18, 2019 (Filed With SEC on May 9, 2019)

Amendment N1 to the Manufacturing and Supply Agreement effective 19 March 2014 with PCAS SA, dated July 25, 2018 (Filed With SEC on February 26, 2019)

Corcept Therapeutics Incorporated (29)